ArticleCancers2022

The Clonal Diversity of Peripheral B Cell Receptor Immune Repertoire Impaired by Residual Malignant B Cells Predicts Treatment Efficacy in B Cell Lymphoma Patients.

Meng Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.